Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
Gogas Helen, Dafni Urania, Koon Henry, Spyropoulou-Vlachou Maria, Metaxas Yannis, Buchbinder Elizabeth, Pectasides Eirini, Tsoutsos Dimosthenis, Polyzos Aristidis, Stratigos Alexandros, Markopoulos Christos, Panagiotou Petros, Fountzilas George, Castana Ourania, Skarlos Pantelis, Atkins, Kirkwood